135 related articles for article (PubMed ID: 16253033)
1. Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings.
Pai RK; Snider WK; Starkey CR; Viswanatha D; Foucar MK; Wilson CS
Arch Pathol Lab Med; 2005 Nov; 129(11):1487-90. PubMed ID: 16253033
[TBL] [Abstract][Full Text] [Related]
2. Nonsecretory alpha-chain disease with immunoproliferative small-intestinal disease.
Matuchansky C; Cogné M; Lemaire M; Babin P; Touhard G; Chamaret S; Preud'homme JL
N Engl J Med; 1989 Jun; 320(23):1534-9. PubMed ID: 2498659
[No Abstract] [Full Text] [Related]
3. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms.
Al-Saleem T; Al-Mondhiry H
Blood; 2005 Mar; 105(6):2274-80. PubMed ID: 15542584
[TBL] [Abstract][Full Text] [Related]
4. Immunoproliferative small intestinal disease: a study of 13 cases with alpha heavy-chain disease.
Price SK
Histopathology; 1990 Jul; 17(1):7-17. PubMed ID: 2227833
[TBL] [Abstract][Full Text] [Related]
5. Immunoproliferative small intestinal disease associated with Campylobacter jejuni.
Lecuit M; Abachin E; Martin A; Poyart C; Pochart P; Suarez F; Bengoufa D; Feuillard J; Lavergne A; Gordon JI; Berche P; Guillevin L; Lortholary O
N Engl J Med; 2004 Jan; 350(3):239-48. PubMed ID: 14724303
[TBL] [Abstract][Full Text] [Related]
6. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
[TBL] [Abstract][Full Text] [Related]
7. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
Vaiphei K; Kumari N; Sinha SK; Dutta U; Nagi B; Joshi K; Singh K
World J Gastroenterol; 2006 Jun; 12(22):3602-8. PubMed ID: 16773719
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection].
Cui M; Hu F; Jiang H; Zheng X
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1245-8. PubMed ID: 12425803
[TBL] [Abstract][Full Text] [Related]
9. Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.
Adamek RJ; Pfaffenbach B; Szymanski C
Helicobacter; 1998 Sep; 3(3):206-11. PubMed ID: 9731993
[TBL] [Abstract][Full Text] [Related]
10. Immunoproliferative small intestinal disease without alpha-chain disease: a pathological study.
Cammoun M; Jaafoura H; Tabbane F; Halphen M
Gastroenterology; 1989 Mar; 96(3):750-63. PubMed ID: 2914638
[TBL] [Abstract][Full Text] [Related]
11. [Role of pantoprazole in the eradicating treatment of Helicobacter pylori].
Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
Rev Clin Esp; 1998 Oct; 198(10):678-83. PubMed ID: 9844458
[No Abstract] [Full Text] [Related]
12. "Mediterranean lymphoma" treated with antibiotics.
Matsumoto S; Kinoshita Y; Fukuda H; Waki S; Asahara M; Matsushima Y; Kawanami C; Fujimori T; Chiba T
Intern Med; 1996 Dec; 35(12):961-5. PubMed ID: 9030995
[TBL] [Abstract][Full Text] [Related]
13. A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.
Bilardi C; Dulbecco P; Zentilin P; Reglioni S; Iiritano E; Parodi A; Accornero L; Savarino E; Mansi C; Mamone M; Vigneri S; Savarino V
Clin Gastroenterol Hepatol; 2004 Nov; 2(11):997-1002. PubMed ID: 15551252
[TBL] [Abstract][Full Text] [Related]
14. [Morphologic changes of the small intestine and lymph nodes in alpha-chain disease].
Zhuravlev AP; Petrukhin SV; Rebrov VG
Arkh Patol; 1988; 50(8):74-80. PubMed ID: 3143343
[TBL] [Abstract][Full Text] [Related]
15. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.
Pilotto A; Leandro G; Franceschi M; Bierti L; Di Battista R; Notarbartolo A; Pisciotta G; Grassi A; Crestani B; Tafner G; Michelagnoli S; Garotta F
Hepatogastroenterology; 1999; 46(25):245-51. PubMed ID: 10228801
[TBL] [Abstract][Full Text] [Related]
16. Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.
Wöhrer S; Bartsch R; Hejna M; Drach J; Raderer M
Scand J Gastroenterol; 2005 Oct; 40(10):1222-5. PubMed ID: 16265779
[TBL] [Abstract][Full Text] [Related]
17. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study.
Nair S; Mathan M; Ramakrishna BS; Mathan VI
J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication for the treatment of dyspeptic symptoms in chronic renal failure.
Simunić M; Ljutić D; Mise S; Pesutić-Pisac V; Tonkić M; Hozo I
Ann Saudi Med; 2005; 25(5):425-7. PubMed ID: 16270770
[No Abstract] [Full Text] [Related]
19. Immunoproliferative Small Intestinal Disease in a Liver Transplant Recipient: A Case Report and Literature Review.
Orfanoudaki E; Iliadis A; Goulis I; Xylouri E; Voumvouraki A; Samonakis DN
Exp Clin Transplant; 2021 Jun; 19(6):620-623. PubMed ID: 34085608
[TBL] [Abstract][Full Text] [Related]
20. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.
Fischbach W; Tacke W; Greiner A; Konrad H; Müller-Hermelink
Lancet; 1997 Jan; 349(9044):31-2. PubMed ID: 8988128
[No Abstract] [Full Text] [Related]
[Next] [New Search]
